2027 ICD-10-CM Diagnosis Code C96Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

ICD-10-CM Codes›C00–D49›C81-C96›C96

ICD-10-CM C96
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

C96 is a non-billable ICD-10-CM category code for other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue, so it cannot be submitted on claims. Use a more specific code from this category instead, such as C96.0, C96.20, C96.21, and C96.22.

Code Identity

ICD-10-CM Code
C96
Billable Status
No — Non-Billable Category
Code Describes
Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
Short Description
Oth & unsp malig neoplm of lymphoid, hematpoetc and rel tiss
Chapter
C81-C96
Malignant neoplasms of lymphoid, hematopoietic and related tissue

Code Classification

ChapterC00–D49Neoplasms
SectionC81-C96Malignant neoplasms of lymphoid, hematopoietic and related tissue
CategoryC96Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
This CodeC96Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

Specific Coding for Oth & unsp malig neoplm of lymphoid, hematpoetc and rel tissOverview

Non-specific codes like C96 require more characters. Use one of these billable codes instead:

  • Use C96.0 for Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis

  • C96.2 for Malignant mast cell neoplasm

  • Use C96.20 for Malignant mast cell neoplasm, unspecified

  • Use C96.21 for Aggressive systemic mastocytosis

  • Use C96.22 for Mast cell sarcoma

  • Use C96.29 for Other malignant mast cell neoplasm

  • Use C96.4 for Sarcoma of dendritic cells (accessory cells)

  • Use C96.5 for Multifocal and unisystemic Langerhans-cell histiocytosis

  • Use C96.6 for Unifocal Langerhans-cell histiocytosis

  • Use C96.9 for Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified

  • Use C96.A for Histiocytic sarcoma

  • Use C96.Z for Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to C96: its own notes plus those printed at block C81-C96 and Chapter 2. A note printed at a category, block or chapter applies to every code under it.

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

  • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From Block C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue applies to 533 codes
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

Notes

General instructions on how these codes are used.

From Chapter 2 (C00-D49) Neoplasms applies to 1,730 codes
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name C96, its category, or a range that includes it.

Applicable To 2

These notes mention C96.

  • Z80.7 Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissues
    Conditions classifiable to C81-C90, C96.-
  • Z85.79 Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues
    Conditions classifiable to C88-C90, C96

Excludes1 1

These codes carry an Excludes1 note naming C96: they are not reported together with it, unless the two conditions are unrelated.

  • C77 Secondary and unspecified malignant neoplasm of lymph nodes
    malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)

Patient EducationClinical

Leukemia

Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job:

The full article covers:

  • What is leukemia?
  • What are the types of leukemia?
  • What causes leukemia?
  • Who is at risk for leukemia?
  • What are the symptoms of leukemia?
  • How is leukemia diagnosed?
  • What are the treatments for leukemia?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About C96Overview

Is C96 a billable code?

No. This is a category header that groups the codes for other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue, and headers cannot be submitted on claims. Claims for other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue need a more specific code from this category, such as C96.0, C96.20, and C96.21.

Can C96 be reported with Z85.79?

Not as a rule. The Excludes1 note on C96 lists "personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).